Information Provided By:
Fly News Breaks for August 11, 2015
CRIS
Aug 11, 2015 | 07:40 EDT
RBC Capital noted that Curis' stock has been weak recently. However, the firm thinks the company has had "positive news on several fronts," including pipeline diversification, highly positive data for its CUDC-907 in r/r DLBCL, ad its partnership with Aurigene,. The firm says that if Curis' Phase I trial results at the end of 2015/early 2016 are successful, the company could easily launch a partnership and may become a takeover target. RBC keeps an Outperform rating on the shares.
News For CRIS From the Last 2 Days
There are no results for your query CRIS